Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Density-Lipoprotein-cholesterol Level”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07619131
What this trial is testing

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

Who this might be right for
Hypercholesterolaemia
AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT00654173
What this trial is testing

Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)

Who this might be right for
Hypercholesterolemia
AstraZeneca 4,444
Early research (Phase 1)Study completedNCT03427710
What this trial is testing

A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Who this might be right for
Hypercholesterolemia
Civi Biopharma, Inc. 36
Not applicableStudy completedNCT05218005
What this trial is testing

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Who this might be right for
Familial HypercholesterolemiaFamilial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein BFamilial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation+5 more
University of British Columbia 140
Post-approval studies (Phase 4)Looking for participantsNCT07824323
What this trial is testing

Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromesDyslipidemia
Taipei Medical University Hospital 400
Not applicableEnded earlyNCT04128475
What this trial is testing

Observational Study of Cardiovascular Disease.

Who this might be right for
Cardiovascular DiseasesCardiovascular MorbidityCoronary Heart Disease+1 more
University of Sydney 1,137
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Post-approval studies (Phase 4)Study completedNCT00747149
What this trial is testing

A Diabetes Study to Treat A Population Previously Not at Target

Who this might be right for
Type 2 Diabetes
AstraZeneca 598
Large-scale testing (Phase 3)Ended earlyNCT01294683
What this trial is testing

Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)

Who this might be right for
Primary HypercholesterolemiaDyslipidemia
Merck Sharp & Dohme LLC 977
Not applicableStudy completedNCT00999453
What this trial is testing

The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients

Who this might be right for
Hypercholesterolemia
Clinical Research Center for End Stage Renal Disease, Korea 43
Post-approval studies (Phase 4)UnknownNCT02579499
What this trial is testing

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Diseasse
Yonsei University 4,400
Large-scale testing (Phase 3)Study completedNCT07253584
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 720
Not applicableUnknownNCT05081336
What this trial is testing

Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry

Who this might be right for
Acute Coronary SyndromeDyslipidemias
University Clinical Centre of Republic of Srpska 500
Large-scale testing (Phase 3)Study completedNCT00654602
What this trial is testing

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Who this might be right for
Dyslipidaemia
AstraZeneca 1,500
Not applicableStudy completedNCT02341664
What this trial is testing

Patient and Provider Assessment of Lipid Management Registry

Who this might be right for
HyperlipidemiaHypercholesterolemiaCardiovascular Disease+14 more
Duke University 7,658
Large-scale testing (Phase 3)Active Not RecruitingNCT07000123
What this trial is testing

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 3,103
Not applicableStudy completedNCT07409636
What this trial is testing

Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 11,991
Not applicableStudy completedNCT05870657
What this trial is testing

Adherence and Persistence to Inclisiran Among Early Users in Germany

Who this might be right for
High Levels of Low-density Lipoprotein Cholesterol
Novartis Pharmaceuticals 1,109
Not applicableStudy completedNCT04223557
What this trial is testing

A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation

Who this might be right for
Visceral ObesityUltrasound TherapyDyslipidemias
The First Affiliated Hospital with Nanjing Medical University 84
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Next Page